Related Experiment Videos
Scott syndrome: a disorder of platelet coagulant activity
1Department of Medicine, St Luke's-Roosevelt Hospital Center, New York, NY 10019.
Seminars in Hematology
|October 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preclinical characterization of 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic acid metabolism: in vitro species comparison and in vivo disposition in rats.
Drug metabolism and disposition: the biological fate of chemicals·2003
Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation.
American journal of hematology·2001
Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.
Seminars in hematology·2026
The current state of cerebral complications of sickle cell disease.
Seminars in hematology·2026
Germline predisposition in myeloproliferative neoplasms.
Seminars in hematology·2026
Monocytic Cell Variations in Postallotransplant Environment: Balancing Graft Versus Host Disease and Graft-Versus-Leukemia Effect.
Journal of immunology research·2026
Establishment of Reference Intervals for Thrombus Biomarkers in a Single-Center Chinese Population Using Indirect Methods.
Journal of clinical laboratory analysis·2026
Re-evaluating haemolysis rejection criteria for PT, aPTT, and D-dimer testing: evidence from paired clinical samples on the CN-3000 analyser.
Advances in laboratory medicine·2026
Medium-term biological variation of sodium, potassium and chloride in whole blood in cohorts of healthy individuals and hemodialysis patients.
Advances in laboratory medicine·2026